• iHealth's Super Bowl Debut Highlights Its Commitment to Bring More Tests to More People ASAP

    iHealth Labs, Inc. made its Super Bowl debut with in-stadium advertising highlighting its commitment to bring at-home COVID-19 tests to more people as quickly as possible. iHealth's Super Bowl advertising featured LED ribbon takeovers and branded openings on the stadium's video board that ran during the breaks at the end of the first and third quarters on Sunday, Feb. 13 at SoFi Stadium.
  • iHealth Statement on the COVID-19 Omicron Variant and Its At-Home Test Kit's Effectiveness

    iHealth has been continuously monitoring the COVID-19 variants so the iHealth COVID-19 Antigen Rapid Test is ready to address any significant changes in the epidemic. We are confident that our rapid antigen test continues to detect COVID-19 infection, including infection with the Omicron variant.
  • Stop the Spread With iHealth's New COVID-19 Self-Test Kit

    iHealth Labs, Inc. announced today the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. This self-test is suitable for individual or group testing anytime, anywhere, and delivers test results in 15 minutes at home. It is authorized and available for purchase at iHealthLabs.com in packages of two test kits.